Semaglutide was approved in 2017 (139)
In that role it is meant to reduce peptide breakdown during manufacturing, storage, and the weeks before use
Rawshani A, Rawshani A, Franzn S, et al
As always, talk to a licensed healthcare provider to determine whether GLP-1 treatment is appropriate for you
The lawsuits claim that Novo Nordisk was aware, or should have been aware, of the potential for these severe side effects but did not provide sufficient warnings to consumers and healthcare professionals
The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam